Unitree Files for $608M STAR Market IPO — China's First Public Pure-Play Humanoid Maker
Unitree Robotics filed a preliminary IPO prospectus with the Shanghai Stock Exchange's Sci-Tech Innovation Board (STAR Market) on March 21, 2026, targeting approximately 4.2 billion yuan (~$608 million USD) in its initial public offering. The filing has been accepted for preliminary review, making Unitree the first Chinese humanoid robotics pure-play to pursue a public listing — and a critical valuation benchmark for the broader Chinese humanoid sector.
The financials disclosed in the prospectus mark Unitree as one of the few humanoid manufacturers with material revenue. Fiscal year 2025 revenue reached ¥1.71 billion (~$235M) — a 335% year-over-year increase — with adjusted net profit of approximately ¥600 million ($83M). The company is one of the only humanoid robotics startups globally generating positive cash flow at scale.
How Unitree got here without western-style capital
Unitree's path to IPO is a notable counterexample to the venture-backed Western model exemplified by Figure AI, Apptronik, and 1X. The company has raised $200M+ across Series A, B, and C — a fraction of what its US peers have absorbed — yet leads the global humanoid market by shipped volume, with 5,500+ humanoid units delivered in 2025 alone.
Founder Xingxing Wang's strategy has been aggressive price-performance positioning and dual-product diversification. The H1 humanoid platform launched at $16,000 and undercuts Western rivals by 5-10x. The G1 follow-up at $13,500 prioritized accessibility for university research and small-scale industrial users. Crucially, Unitree's quadruped business — the Go2 and B2 series — generates the cash flow that has subsidized humanoid development. Cumulative quadruped shipments crossed 30,000 units through 2025.
What the IPO valuation reveals
A $608M raise at the typical STAR Market dilution range (15-25%) implies a post-money valuation between $2.4B and $4B. This positions Unitree below the most aggressive Western valuations — Figure AI at $39B, Skild AI at $14B, Physical Intelligence at $11B+ — but above AGIBot's reported ~$2.1B private valuation.
The disclosed revenue profile changes the conversation. Western humanoid companies trade at 50-200x speculative multiples on negligible commercial revenue. Unitree at $235M of 2025 revenue and ~$83M of profit would IPO at roughly 10-20x trailing revenue and 30-50x earnings — a recognizable price-to-fundamentals ratio for a high-growth tech company.
Implications for the Chinese humanoid market
Unitree's STAR Market filing arrives alongside AGIBot's separate Hong Kong IPO preparation, which is targeting a Q3 2026 listing. Together, these listings will establish the first publicly-tradeable Chinese humanoid pure-plays — providing benchmarking data for Chinese sovereign wealth and institutional capital that has so far funneled almost exclusively to private rounds.
The Chinese humanoid manufacturing flywheel — Unitree, AGIBot, UBTECH, Fourier, RobotEra, Galbot, and dozens of smaller players — is now accelerating on a different commercial trajectory than the Western enterprise/consumer split. Public market access at scale could compound this advantage.
What to watch next
The STAR Market preliminary review process typically takes 6-12 months. A successful Unitree listing in late 2026 or early 2027 would precede most Western humanoid IPOs and establish a Chinese benchmark before Figure or Apptronik approach public markets. The pricing, lock-up structure, and post-IPO trading behavior will reshape how investors price the entire global humanoid sector.